Definitive Contract HHSN261201000134C

Ended Awarded Last action

Contract number
HHSN261201000134C
Awardee
Awarding agency
Obligated
$199,860

Award facts

Contract value 100% obligated
$199,860.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 11 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Roxbury, MA 02118, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 · Deliverable modification $0
Original award $199,860

About this award

This is a federal contract award from the National Cancer Institute, a civilian agency, to Eutropics Pharmaceuticals, a small business contractor. The contract has a Ceiling Value of $199,860.00 and is a Definitive Contract with a Firm Fixed Price pricing type. The contract was awarded on September 30, 2010 with an Ultimate Completion Date of June 29, 2011. The place of performance is Boston, MA. This appears to be a standalone contract award and not part of a larger contract vehicle. The contract has a Total Small Business set aside designation.

Quick answers

Who was awarded contract HHSN261201000134C?

HHSN261201000134C was awarded to Eutropics Pharmaceuticals Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2010.

How much is contract HHSN261201000134C worth?

The government has obligated $199,860 on HHSN261201000134C.

Was contract HHSN261201000134C competed?

The extent of competition for HHSN261201000134C was full and open competition after exclusion of sources. The government received 11 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award